Race Oncology Ltd has released a press release.
March 2025 Quarterly Activity Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Racura Oncology
- Enrolment Opened at Second Site for RC220 Phase 1 Trial
- RC220 Phase 1 Trial Opens for Patient Enrolment
- Race Initiates First AU Site for Phase 1 Solid Tumour Trial
- Ethics approval received for RC220 Phase 1 Trial
- S&P DJI Announces March 2025 Quarterly Rebalance
Later from Racura Oncology
- First Patient Dosed Safely in RC220 Phase 1 Trial
- First Patient Safely Combine Dosed in Phase 1 RC220 Trial
- RC220 Human Ethics Approvals Received in Hong Kong
- June 2025 Quarterly Activity Report and Appendix 4C
- Appendix 4E & Annual Report
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology